A recent genome-wide in vivo CRISPR screen identified IFN-induced upregulation of classical and non-classical MHC class I inhibitory checkpoints as tumor-intrinsic immune evasion mechanisms (29). This evidence concerns the gene IFNA1 and neoplasm.